Results 21 to 30 of about 26,453 (213)
Osteomalacia in practice of endocrinologist: etiology, pathogenesis, differential diagnosis with osteoporosis [PDF]
Остеопороз и остеопатии, 2020 Osteoporosis is the most common cause of low bone mineral density (BMD) and low-traumatic fractures in adults. However, differential diagnosis should also consider other causes of decreased BMD, including osteomalacia, as treatment for these conditions ...
Olga O. Golounina +2 more
doaj +1 more source
Epidemiology of Tumor-Induced Osteomalacia in Denmark
Calcified Tissue International, 2021 Tumor-induced osteomalacia (TIO) is a rare, acquired condition of phosphate wasting due to phosphaturic mesenchymal tumors. Because the incidence and prevalence of TIO is unknown, we conducted an observational cohort study using national Danish health ...
B. Abrahamsen +2 more
semanticscholar +1 more source
Nasal Hemangiopericytoma Causing Oncogenic Osteomalacia [PDF]
Clinical and Experimental Otorhinolaryngology, 2012 Oncogenic osteomalacia is a rare cause that makes abnormalities of bone metabolism. Our case arose in a 47-year-old woman presenting a nasal mass associated with osteomalacia. We excised the mass carefully.
Sung Il Cho +3 more
doaj +1 more source
Comparative Analysis of Clinical and Imaging Features of Osteomalacia and Spondyloarthritis
Frontiers in Medicine, 2021 Aim: To compare the clinical and radiological characteristics of osteomalacia and spondyloarthritis/ankylosing spondylitis (SpA/AS) in order to provide a basis for differential diagnosis.Methods: We carried out a retrospective analysis of patients who ...
Zheng Zhao +6 more
doaj +1 more source
Oncogenic osteomalacia secondary to glomus tumor
Endocrinology, Diabetes & Metabolism Case Reports, 2021 Oncogenic osteomalacia secondary to glomus tumor is extremely rare. Localization of causative tumors is critical as surgical resection can lead to a complete biochemical and clinical cure.
Rishi Raj +10 more
doaj +1 more source
Burosumab for the Treatment of Tumor‐Induced Osteomalacia
Journal of Bone and Mineral Research, 2020 Tumor‐induced osteomalacia (TIO) is caused by phosphaturic mesenchymal tumors producing fibroblast growth factor 23 (FGF23) and is characterized by impaired phosphate metabolism, skeletal health, and quality of life.
S. M. Jan de Beur +11 more
semanticscholar +1 more source
Fluoridated Water-Induced Osteomalacia in the Population of Mirpurkhas
JLUMHS, 2023 OBJECTIVE: To investigate the prevalence and impact of fluoridated water consumption on osteomalacia in the population of Mirpurkhas, focusing on understanding the relationship between fluoride levels in water sources and the incidence of osteomalacia ...
Mir Mehrab Jan Khetran +5 more
doaj +1 more source
FGF23-related hypophosphatemic rickets/osteomalacia: diagnosis and new treatment.
Journal of Molecular Endocrinology, 2020 FGF23 is a phosphaturic hormone produced by bone. FGF23 reduces serum phosphate by suppressing proximal tubular phosphate reabsorption and intestinal phosphate absorption.
S. Fukumoto
semanticscholar +1 more source
Journal of Bone and Mineral Research, 2020 Patients with tumor‐induced osteomalacia (TIO), an acquired paraneoplastic condition characterized by osteomalacia due to hypophosphatemia, exhibit a similar clinical picture to those with X‐linked hypophosphatemic rickets/osteomalacia (XLH).
Y. Imanishi +11 more
semanticscholar +1 more source
Osteoporosis and osteomalacia - clinical and diagnostic problems
Travmatologiâ i Ortopediâ Rossii, 2016 Aim: to define main clinical and diagnostical problems related to osteoporosis and osteomalacia. Literature data showed that not only osteoporosis but osteomalacia may be the reason for decreasing of mechanical properties of skeleton with risk of low ...
A. S. Avrunin
doaj +1 more source